Can estrogens promote hypertension during systemic lupus erythematosus?

Steroids

Volumn 75, Issue 11, 2010, Pages 766-771

  Venegas Pont, Marcia ^a   Ryan, Michael J ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Estrogen; Hormone; Hypertension; Immune; Inflammation; Lupus

Indexed keywords

ESTROGEN;

ARTICLE; CARDIOVASCULAR RISK; HUMAN; HYPERTENSION; IMMUNE SYSTEM; INFLAMMATION; PREVALENCE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ESTROGENS; HUMANS; HYPERTENSION; IMMUNE SYSTEM; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, ANIMAL;

EID: 77955922330     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.02.010     Document Type: Article

References (78)

1. S. Bernatsky, J.F. Boivin, L. Joseph, S. Manzi, E. Ginzler, and D.D. Gladman Mortality in systemic lupus erythematosus Arthritis Rheum 54 August (8) 2006 2550 2557
2. M.B. Urowitz, A.A. Bookman, B.E. Koehler, D.A. Gordon, H.A. Smythe, and M.A. Ogryzlo The bimodal mortality pattern of systemic lupus erythematosus Am J Med 60 February (2) 1976 221 225
3. L.B. Tucker, S. Menon, J.G. Schaller, and D.A. Isenberg Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome Br J Rheumatol 34 September (9) 1995 866 872
4. J.S. Smolen Therapy of systemic lupus erythematosus: a look into the future Arthritis Res 4 Suppl. 3 2002 S25 S30
5. Y. Kitagawa, F. Gotoh, A. Koto, and H. Okayasu Stroke in systemic lupus erythematosus Stroke 21 November (11) 1990 1533 1539
6. P. Riboldi, M. Gerosa, C. Luzzana, and L. Catelli Cardiac involvement in systemic autoimmune diseases Clin Rev Allergy Immunol 23 December (3) 2002 247 261
7. G.N. Thomas, L.S. Tam, B. Tomlinson, and E.K. Li Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention Hong Kong Med J 8 February (1) 2002 26 32
8. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger Jr., and L. Jansen-McWilliams Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study Am J Epidemiol 145 March (5) 1997 408 415
9. Health, United States 2007 with chartbook on trends in health of Americans 2007 National Center for Health Statistics Hyattsville, MD
10. D.R. Budman, and A.D. Steinberg Hypertension and renal disease in systemic lupus erythematosus Arch Intern Med 136 September (9) 1976 1003 1007
11. A. Doria, Y. Shoenfeld, R. Wu, P.F. Gambari, M. Puato, and A. Ghirardello Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus Ann Rheum Dis 62 November (11) 2003 1071 1077
12. M. Petri Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort Lupus 9 3 2000 170 175
13. F. Selzer, K. Sutton-Tyrrell, S. Fitzgerald, R. Tracy, L. Kuller, and S. Manzi Vascular stiffness in women with systemic lupus erythematosus Hypertension 37 April (4) 2001 1075 1082
14. J. Petrin, B. Rozman, P. Dolenc, D. Logar, B. Bozic, and A. Vizjak The dissociation of arterial hypertension and lupus glomerulonephritis in systemic lupus erythematosus Blood Press 2 June (2) 1993 108 112
15. M.M. Ward, and S. Studenski Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking Arch Intern Med 152 October (10) 1992 2082 2088
16. V.R. Kelley, and R.P. Wuthrich Cytokines in the pathogenesis of systemic lupus erythematosus Semin Nephrol 19 January (1) 1999 57 66
17. L.E. Bautista, L.M. Vera, I.A. Arenas, and G. Gamarra Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension J Hum Hypertens 19 February (2) 2005 149 154
18. C.U. Chae, R.T. Lee, N. Rifai, and P.M. Ridker Blood pressure and inflammation in apparently healthy men Hypertension 38 September (3) 2001 399 403
19. T.J. Guzik, N.E. Hoch, K.A. Brown, L.A. McCann, A. Rahman, and S. Dikalov Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction J Exp Med 204 October (10) 2007 2449 2460
20. D.L. Mattson, L. James, E.A. Berdan, and C.J. Meister Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat Hypertension 48 July (1) 2006 149 156
21. M. Venegas-Pont, J.C. Sartori-Valinotti, C. Maric, L.C. Racusen, P.H. Glover, and G.R. McLemore Jr. Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus Am J Physiol Regul Integr Comp Physiol 296 April (4) 2009 R1282 R1289
22. E.J. Kovacs, K.A. Messingham, and M.S. Gregory Estrogen regulation of immune responses after injury Mol Cell Endocrinol 193 July (1-2) 2002 129 135
23. T.J. Lang Estrogen as an immunomodulator Clin Immunol 113 December (3) 2004 224 230
24. A. Doria, L. Iaccarino, P. Sarzi-Puttini, A. Ghirardello, S. Zampieri, and S. Arienti Estrogens in pregnancy and systemic lupus erythematosus Ann N Y Acad Sci 1069 June 2006 247 256
25. Y. Uemura, T.Y. Liu, Y. Narita, M. Suzuki, and S. Matsushita 17 beta-estradiol (E2) plus tumor necrosis factor-alpha induces a distorted maturation of human monocyte-derived dendritic cells and promotes their capacity to initiate T-helper 2 responses Hum Immunol 69 March (3) 2008 149 157
26. M.L. Salem Estrogen a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production Curr Drug Targets Inflamm Allergy 3 March (1) 2004 97 104
27. P. Druet, R. Sheela, and L. Pelletier Th1, Th2 cells in autoimmunity Clin Exp Immunol 101 July (Suppl. 1) 1995 9 12
28. R.W. McMurray Estrogen, prolactin, and autoimmunity: actions and interactions Int Immunopharmacol 1 June (6) 2001 995 1008
29. G. Yao, and Y. Hou Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway Int Immunopharmacol 4 February (2) 2004 213 221
30. I. Screpanti, D. Meco, S. Morrone, A. Gulino, B.J. Mathieson, and L. Frati In vivo modulation of the distribution of thymocyte subsets: effects of estrogen on the expression of different T cell receptor V beta gene families in CD4-, CD8-thymocytes Cell Immunol 134 May (2) 1991 414 426
31. T.J. Lang, P. Nguyen, J.C. Papadimitriou, and C.S. Via Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells J Immunol 171 December (11) 2003 5795 5801
32. V. Rider, R.T. Foster, M. Evans, R. Suenaga, and N.I. Abdou Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus Clin Immunol Immunopathol 89 November (2) 1998 171 180
33. V. Rider, S.R. Jones, M. Evans, and N.I. Abdou Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells Clin Immunol 95 May (2) 2000 124 134
34. H. Carlsten Immune responses and bone loss: the estrogen connection Immunol Rev 208 December 2005 194 206
35. C.M. Grimaldi, D.J. Michael, and B. Diamond Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus J Immunol 167 August (4) 2001 1886 1890
36. M. Folomeev, M. Dougados, J. Beaune, J.C. Kouyoumdjian, K. Nahoul, and B. Amor Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus Lupus 1 May (3) 1992 191 195
37. R.W. McMurray, and W. May Sex hormones and systemic lupus erythematosus: review and meta-analysis Arthritis Rheum 48 August (8) 2003 2100 2110
38. R.G. Lahita, H.L. Bradlow, E. Ginzler, S. Pang, and M. New Low plasma androgens in women with systemic lupus erythematosus Arthritis Rheum 30 March (3) 1987 241 248
39. M. Cutolo, S. Capellino, A. Sulli, B. Serioli, M.E. Secchi, and B. Villaggio Estrogens and autoimmune diseases Ann N Y Acad Sci 1089 November 2006 538 547
40. J.F. Reckelhoff, and L.A. Fortepiani Novel mechanisms responsible for postmenopausal hypertension Hypertension 43 May (5) 2004 918 923
41. C. Weidler, P. Harle, J. Schedel, M. Schmidt, J. Scholmerich, and R.H. Straub Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens J Rheumatol 31 March (3) 2004 489 494
42. M. Cutolo, A. Sulli, S. Capellino, B. Villaggio, P. Montagna, and B. Seriolo Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity Lupus 13 9 2004 635 638
43. F. Lanfranco, A. Kamischke, M. Zitzmann, and E. Nieschlag Klinefelter's syndrome Lancet 364 July (9430) 2004 273 283
44. R.H. Scofield, G.R. Bruner, B. Namjou, R.P. Kimberly, R. Ramsey-Goldman, and M. Petri Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome Arthritis Rheum 58 August (8) 2008 2511 2517
45. H.F. Pan, W.X. Li, H. Yuan, L.H. Li, J.B. Feng, and J. Li Susceptibility to systemic lupus erythematosus may be related to gene dosage effect of the X chromosome Med Hypotheses 72 January (1) 2009 104 105
46. A. Tandon, D. Ibanez, D.D. Gladman, and M.B. Urowitz The effect of pregnancy on lupus nephritis Arthritis Rheum 50 December (12) 2004 3941 3946
47. G. Moroni, S. Quaglini, G. Banfi, M. Caloni, S. Finazzi, and G. Ambroso Pregnancy in lupus nephritis Am J Kidney Dis 40 October (4) 2002 713 720
48. E. Imbasciati, A. Tincani, G. Gregorini, A. Doria, G. Moroni, and G. Cabiddu Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome Nephrol Dial Transplant 24 February (2) 2009 519 525
49. M. Petri, M.Y. Kim, K.C. Kalunian, J. Grossman, B.H. Hahn, and L.R. Sammaritano Combined oral contraceptives in women with systemic lupus erythematosus N Engl J Med 353 December (24) 2005 2550 2558
50. J.P. Buyon, M.A. Petri, M.Y. Kim, K.C. Kalunian, J. Grossman, and B.H. Hahn The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial Ann Intern Med 142 June (12 Pt 1) 2005 953 962
51. C.C. Mok, C.S. Lau, C.T. Ho, K.W. Lee, M.Y. Mok, and R.W. Wong Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus Scand J Rheumatol 27 5 1998 342 346
52. S. Kreidstein, M.B. Urowitz, D.D. Gladman, and J. Gough Hormone replacement therapy in systemic lupus erythematosus J Rheumatol 24 November (11) 1997 2149 2152
53. J. Hochman, M.B. Urowitz, D. Ibanez, and D.D. Gladman Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease Lupus 18 April (4) 2009 313 317
54. A.D. Sturgess, D.T. Evans, I.R. Mackay, and A. Riglar Effects of the oestrogen antagonist tamoxifen on disease indices in systemic lupus erythematosus J Clin Lab Immunol 13 January (1) 1984 11 14
55. C.C. Mok, C.H. To, A. Mak, and K.M. Ma Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study Arthritis Rheum 52 December (12) 2005 3997 4002
56. S.G. Pasoto, B.B. Mendonca, and E. Bonfa Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations Lupus 11 3 2002 175 180
57. P. Piotrowski, R. Gasik, M. Lianeri, D. Cieslak, M. Wudarski, and P. Hrycaj Asp327Asn polymorphism of sex hormone-binding globulin gene is associated with systemic lupus erythematosus incidence Mol Biol Rep August 2009
58. A. Jonsen, X. Yu, L. Truedsson, O. Nived, G. Sturfelt, and S. Ibrahim Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus Lupus 18 April (4) 2009 309 312
59. M.J. Ryan, G.R. McLemore Jr., and S.T. Hendrix Insulin resistance and obesity in a mouse model of systemic lupus erythematosus Hypertension 48 5 2006 988 993
60. M.J. Ryan, and G.R. McLemore Jr. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus Am J Physiol Regul Integr Comp Physiol 292 2 2007 R736 R742
61. K.K. Bynote, J.M. Hackenberg, K.S. Korach, D.B. Lubahn, P.H. Lane, and K.A. Gould Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB × NZW)F1 mice Genes Immun 9 March (2) 2008 137 152
62. J.L. Svenson, J. EuDaly, P. Ruiz, K.S. Korach, and G.S. Gilkeson Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse Clin Immunol 128 August (2) 2008 259 268
63. E.S. Sobel, J. Gianini, E.J. Butfiloski, B.P. Croker, J. Schiffenbauer, and S.M. Roberts Acceleration of autoimmunity by organochlorine pesticides in (NZB × NZW)F1 mice Environ Health Perspect 113 March (3) 2005 323 328
64. F. Wang, E.S. Sobel, E.J. Butfiloski, and S.M. Roberts Comparison of chlordecone and estradiol effects on splenic T-cells in (NZB × NZW)F(1) mice Toxicol Lett 183 December (1-3) 2008 1 9
65. T. Yoneda, N. Ishimaru, R. Arakaki, M. Kobayashi, T. Izawa, and K. Moriyama Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis Endocrinology 145 May (5) 2004 2384 2391
66. N. Ishimaru, N. Haneji, H. Hamano, Y. Kumiko, M. Takahashi, and Y. Hayashi Accelerated onset of age-related autoimmune lesions in MRL/+ mice by ovariectomy Mech Ageing Dev 93 February (1-3) 1997 145 156
67. W.M. Wu, B.F. Lin, Y.C. Su, J.L. Suen, and B.L. Chiang Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice Scand J Immunol 52 October (4) 2000 393 400
68. L.D. Apelgren, D.L. Bailey, R.L. Fouts, L. Short, N. Bryan, and G.F. Evans The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice Cell Immunol 173 October (1) 1996 55 63
69. A.S. Ansar, W.J. Penhale, and N. Talal Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action Am J Pathol 121 December (3) 1985 531 551
70. M.D. Lockshin Sex differences in autoimmune disease Lupus 15 11 2006 753 756
71. A.H. Sawalha, and S. Kovats Dehydroepiandrosterone in systemic lupus erythematosus Curr Rheumatol Rep 10 August (4) 2008 286 291
72. D. Crosbie, C. Black, L. McIntyre, P.L. Royle, and S. Thomas Dehydroepiandrosterone for systemic lupus erythematosus Cochrane Database Syst Rev 4 2007 CD005114
73. E. Peeva, J. Venkatesh, D. Michael, and B. Diamond Prolactin as a modulator of B cell function: implications for SLE Biomed Pharmacother 58 June (5) 2004 310 319
74. L. Jara-Quezada, A. Graef, and C. Lavalle Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus J Rheumatol 18 March (3) 1991 349 353
75. K.B. Elbourne, D. Keisler, and R.W. McMurray Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus Lupus 7 6 1998 420 427
76. K.O. Stumpe, R. Kolloch, M. Higuchi, F. Kruck, and H. Vetter Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control Lancet 2 July (8031) 1977 211 214
77. A. Leanos-Miranda, J. Marquez-Acosta, G.M. Cardenas-Mondragon, Z.L. Chinolla-Arellano, R. Rivera-Leanos, and S. Bermejo-Huerta Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes J Clin Endocrinol Metab 93 July (7) 2008 2492 2499
78. B.K. Tan, and J.S. Hutchinson Blood pressure, plasma and pituitary prolactin responses to bromocriptine in New Zealand genetically hypertensive and normotensive rats Clin Exp Pharmacol Physiol 16 January (1) 1989 13 18